Woman at beach looking at waves

Sublocade

Sublocade

Sublocade is a once-monthly injectable buprenorphine formulation for the treatment of moderate to severe opioid use disorder (OUD) in patients who have initiated treatment with a transmucosal buprenorphine-containing product followed by dose adjustment for a minimum of seven days.

SUBLOCADE is an injectable, extended-release formulation that uses the ATRIGEL® technology to deliver buprenorphine at a controlled rate over a one month period.

As a once-monthly injectable, SUBLOCADE removes the need for patients to remember to take their medication every day, while providing them with the opportunity to focus on the other parts of their complete treatment program that includes counseling and psychosocial support.
Click here for more information on Sublocade